Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumors × Radiation × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 14 Glioblastoma 14 Breast Neoplasms 12 Lung Neoplasms 9 Oropharyngeal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Astrocytoma 6 Urinary Bladder Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 4 Brain Neoplasms 4 Triple Negative Breast Neoplasms 3 Sarcoma, Ewing 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Gliosarcoma 3 Glioma 3 Carcinoma, Squamous Cell 3 Carcinoma 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Prostate Adenocarcinoma 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm Metastasis 2 Medulloblastoma 2

Interventions

pembrolizumab 4 Cetuximab 4 olaparib 2 atezolizumab 2 Trastuzumab 2 Docetaxel 2 tocilizumab 1 spartalizumab 1 ribociclib 1 pralsetinib 1 pertuzumab 1 lenvatinib 1 ipatasertib 1 inavolisib 1 entrectinib 1 encorafenib 1 dapagliflozin 1 cemiplimab 1 brigimadlin 1 binimetinib 1 alectinib 1 adagrasib 1 Rifampin 1 Pemetrexed 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Itraconazole 1 Irinotecan 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡